EIDD-2749

• Target :

  HCV Protease|||Antiviral|||SARS-CoV|||RSV

• Related Pathways :

  Immunology/Inflammation|||Proteases/Proteasome|||Microbiology/Virology

• Purity :

  0.9739

• Bioactivity :

  EIDD-2749 (4'-FlU), a ribonucleoside analog, is an orally available RdRp inhibitor with spectroscopic antiviral activity that interrupts the replication of respiratory syncytial virus and SARS-CoV-2.EIDD-2749 attenuates lethal infections of pandemic human and highly pathogenic avian influenza viruses.

• Smiles :

  O[C@H]1[C@@H](O[C@@](CO)(F)[C@H]1O)N2C(=O)NC(=O)C=C2

• Molecular Formula :

  C9H11FN2O6

• Molecular Weight :

  262.19

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  1613589-24-4